Browse the following options to find a clinical trial in your area and find out if you may qualify today!

The biggest obstacle in getting a celiac drug to market is recruiting enough patients to participate in clinical trials. We need your help to make better treatments and, one day, a cure for celiac disease a reality.

Current Trials

U.S. Multi-Site

ACeD Study

Kanyos Bio is looking for volunteers with celiac disease to participate in the ACeD Study (Assessment of KAN-101 in Celiac Disease), a phase 1 clinical trial testing the investigational drug KAN-101.

KAN-101 acts by re-educating T cells, or tolerizing them, so they do not respond to gluten antigens.


  • 18-70 years old
  • Biopsy-confirmed celiac disease
  • On a gluten-free diet for at least the last 12 months